182 related articles for article (PubMed ID: 22588472)
1. Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites?
Wevers KP; Bastiaannet E; Poos HP; van Ginkel RJ; Plukker JT; Hoekstra HJ
Ann Surg Oncol; 2012 Nov; 19(12):3913-8. PubMed ID: 22588472
[TBL] [Abstract][Full Text] [Related]
2. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.
van der Ploeg AP; van Akkooi AC; Schmitz PI; van Geel AN; de Wilt JH; Eggermont AM; Verhoef C
Ann Surg Oncol; 2011 Nov; 18(12):3300-8. PubMed ID: 21537867
[TBL] [Abstract][Full Text] [Related]
4. Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.
Mozzillo N; Caracò C; Marone U; Di Monta G; Crispo A; Botti G; Montella M; Ascierto PA
World J Surg Oncol; 2013 Feb; 11():36. PubMed ID: 23379355
[TBL] [Abstract][Full Text] [Related]
5. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
6. Regional control and morbidity after superficial groin dissection in melanoma.
Shada AL; Slingluff CL
Ann Surg Oncol; 2011 May; 18(5):1453-9. PubMed ID: 21136182
[TBL] [Abstract][Full Text] [Related]
7. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
8. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
[TBL] [Abstract][Full Text] [Related]
10. The management of cervical lymph nodes in patients with cutaneous melanoma.
Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant irradiation for axillary metastases from malignant melanoma.
Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.
de Vries M; Hoekstra HJ; Hoekstra-Weebers JE
Ann Surg Oncol; 2009 Oct; 16(10):2840-7. PubMed ID: 19639366
[TBL] [Abstract][Full Text] [Related]
15. Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection?
van der Ploeg IM; Valdés Olmos RA; Kroon BB; Nieweg OE
Ann Surg Oncol; 2008 May; 15(5):1485-91. PubMed ID: 18324444
[TBL] [Abstract][Full Text] [Related]
16. Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site.
Prens SP; van der Ploeg AP; van Akkooi AC; van Montfort CA; van Geel AN; de Wilt JH; Eggermont AM; Verhoef C
Ann Surg Oncol; 2011 Dec; 18(13):3586-92. PubMed ID: 21611857
[TBL] [Abstract][Full Text] [Related]
17. Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.
Theodore JE; Frankel AJ; Thomas JM; Barbour AP; Bayley GJ; Allan CP; Wagels M; Smithers BM
ANZ J Surg; 2017 Jan; 87(1-2):44-48. PubMed ID: 27102082
[TBL] [Abstract][Full Text] [Related]
18. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
19. Squamous Cell Carcinoma with Regional Metastasis to Axilla or Groin Lymph Nodes: a Multicenter Outcome Analysis.
Pang G; Look Hong NJ; Paull G; Dobransky J; Kupper S; Hurton S; Kagedan DJ; Quan ML; Helyer L; Nessim C; Wright FC
Ann Surg Oncol; 2019 Dec; 26(13):4642-4650. PubMed ID: 31440926
[TBL] [Abstract][Full Text] [Related]
20. Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.
Holtkamp LH; Wang S; Wilmott JS; Madore J; Vilain R; Thompson JF; Nieweg OE; Scolyer RA
Ann Surg Oncol; 2015 Sep; 22(9):2972-7. PubMed ID: 25990968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]